Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994
The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994
Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994
Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994
Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994
Treatment of Multiple Sclerosis
Lancet 343:275-279, Ebers,G.C., 1994
4-Aminopyridine in the Treatment of Patients with Multiple Sclerosis:Long-term Efficacy and Safety
Arch Neurol 51:292-296, Polman,C.H.,et al, 1994
Megadose Corticosteroids in Multiple Sclerosis
Neurol 44:1-4, Kupersmith,M.J.,et al, 1994
Subcortical Infarction in Children
Stroke 25:117-121, Powell,F.C.,et al, 1994
Tizanidine Treatment of Spasticity Caused by Multiple Sclerosis:Results of a Double-Blinded, Placebo-Controlled Trial
Neurol 44:S34-S43, Smith,C.,et al, 1994
A Double-Blind, Placebo-Controlled Trial of Tizanidine in the Treatment of Spasticity Caused by Multiple Sclerosis
Neurol 44:S70-S78, Barnes,M.P.,et al, 1994
Early, Evolving Wallerian Degeneration of the Pyramidal Tract in Cerebrovascular Diseases:MR Study
J Comput Assist Tomogr 18:943-946, Orita,T.,et al, 1994
Imaging of Cerebral Infarction Caused by Atrial Myxoma
Neuroradiology 36:271-272, Gee,G.T.,et al, 1994
Clinical and Magnetic Resonance Features of the Classic & Akinetic-Rigid Variants of Huntington's Dis
Arch Neurol 50:17-19, Oliva,D.,et al, 1993
Oral Megadose Methylprednisolone Therapy in a Pt with Chronic Progressive MS
Neurol 43:230, Gucuyener,K.,et al, 1993
Plasmapheresis in Acute Episodes of Fulminant CNS Inflammatory Demyelination
Neurol 43:1100-1104, Rodriquez,M.,et al, 1993
Long-Term Safety of Azathioprine Therapy in Multiple Sclerosis
Neurol 43:831-833, Amato,M.P.,et al, 1993
Intermittent Cyclophosphamide Pulse Therapy in Progressive MS:NE Coop MS Trtm Grp
Neurol 43:910-918, Weiner,H.L.,et al, 1993
Computed Tomographic Evidence of an Extensive Thrombosis and Infarction of the Deep Venous System
Stroke 24:744-746, Ur-Rahman,N.&Al-Tahan,A.R., 1993
Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993
Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993
Necrosis of the Putamen Caused by Methanol Intoxication:MR Findings
AJR 160:1105-1106, Glazer,M.&Dross,P., 1993
Short-Cycle Periodic Alternating (Ping-Pong) Gaze
Neurol 43:1067-1070, Ishikawa,H.,et al, 1993
Mitochondrial Encephalomyopathy, Lactic Acidosis, Stroke-Like Episodes (MELAS) :Clinical, Radiological, Pathol & Genetic Observ
Ann Neurol 34:25-31, Koo,B.,et al, 1993
Methylprednisolone in Multiple Sclerosis:A Comparison of Oral with Intravenous Therapy at Equivalent High Dose
JNNP 56:1219-1220, Alam,S.M.,et al, 1993
MRI Abnormalities in Creutzfeldt-Jakob Disease
Neuroradiology 35:584-585, DiRocco,A.,et al, 1993
Mycoplasma Pneumoniae Infection May Cause Striatal Lesions Leading to Acute Neurologic Dysfunction
Neurol 43:2150-2151, Saitoh,S.,et al, 1993
Lesions of Basal Ganglia Due to Disulfiram Neurotoxicity
JNNP 55:925-929, Laplane,D.,et al, 1992
Serial Changes of Cerebral Glucose Metab & Caudate Size in Persons at Risk for Huntington's Dis
Arch Neurol 49:1161-1167, Grafton,S.T.,et al, 1992
Open Controlled Therapeutic Trial of Intravenous Immune Globulin in Relapsing-Remitting Multiple Sclerosis
Arch Neurol 49:1233-1236, Achiron,A.,et al, 1992
Multiple Sclerosis:The Impact of MR Imaging
AJR 158:849-857, Wallace,C.J.,et al, 1992
The Effect of 4-Aminopyridine on Clinical Signs in Multiple Sclerosis
Ann Neurol 32:123-130, vanDiemen,H.A.M.,et al, 1992
A Double-Blind, Renadomized, Crossover Trial of Pemoline in Fatigue Assoc with Multiple Sclerosis
Neurol 42:1468-1471, Weinshenker,B.G.,et al, 1992
DDAVP in the Management of Nocturia in Multiple Sclerosis
Ann Neurol 31:577, Valiquette,G.,et al, 1992
Locations of Cerebral Infarctions in Tuberculous Meningitis
Neuroradiology 34:197-199, Hsieh,F-Y.,et al, 1992
Cerebrovascular Complications of Primary Herpes Varicella-Zoster Infection
Editorial, Lancet 339:1449-14501992., , 1992
Delayed Cyanide Induced Dystonia
JNNP 55:198-199, Valenzuela,R.,et al, 1992
Putamen Volume Reduction on Magnetic Resonance Imaging Exceeds Caudate Changes in Mild Huntington's Disease
Ann Neurol 31:69-75, Harris,G.J.,et al, 1992
A Correlative Triad of Gadolinium-DTPA MRI, EDSS, & CSF-MBP in Relapsing MS Treated with High-Dose Intravenous Methylprednisolone
Neurol 42:63-67, Barkhof,F.,et al, 1992
Atypical MR Presentation of Wilson Disease:A Possible Consequence of Paramagnetic Effect of Copper
Neuroradiology 34:222-224, Brugieres,P.,et al, 1992
Chronic Acquired Hepatic Failure:MR Imaging of the Brain at 1. 5 T
AJR 157:1111-1116, Brunberg,J.A.,et al, 1991
Parkinsonism and Defects of Praxis Following Methanol Poisoning
JNNP 54:843-844, Mozaz,M.J.,et al, 1991
Methanol Poisoning:Bilateral Putaminal and Cerebellar Cortical Lesions on CT & MR
J Comput Assist Tomogr 15:522-524, Chen,J.C.,et al, 1991
Magnetic Resonance Imaging, Computed Tomography, and Autopsy Findings after Cardiorespiratory Arrest
J Neuroimag 1:197-199, Schmidt,R.,et al, 1991
Overview of Azathioprine Treatment in Multiple Sclerosis
Lancet 338:1051-1055, Yudkin,P.L.,et al, 1991
Intense Immunosuppression in Chronic Progressive Multiple Sclerosis:The Kaiser Study
JNNP 54:1055-1060, Likosky,W.H.,et al, 1991
Treatment of Multiple Sclerosis with Hyperbaric Oxygen
Arch Neurol 48:195-199, Kindwall,E.P.,et al, 1991
The Efficacy of Azathiorpine in Relapsing-Remitting Multiple Sclerosis
Neurol 41:20-25, Goodkin,D.E.,et al, 1991
The Canadian Coop Trial of Cyclophosphamide and Plasma Exchange in Progr MS
The Canadian Coop MS Study Group, Lancet 337:441-4461991., , 1991
Plasma Exchange in Chronic Progressive Multiple Sclerosis:A Long-Term Study
Neurol 41:409-414, Khatri,B.O.,et al, 1991